Table 4. Postoperative outcomes.
| Non-conversion (n=248) | Conversion (n=26) | ||||||||
| n | % | Median | IQR1-IQR3 | n | % | Median | IQR1-IQR3 | p | |
| Operative mortality | 0 | 0.0 | 1 | 3.8 | 0.09 | ||||
| New-onset atrial fibrillation | 32 | 12.9 | 6 | 23.1 | 0.22 | ||||
| Acute renal failure | 2 | 0.8 | 0 | 0.0 | 0.99 | ||||
| Re-exploration | 22 | 8.9 | 3 | 11.5 | 0.71 | ||||
| Prolonged inotrope use (>24 h) | 9 | 3.6 | 1 | 3.8 | 0.99 | ||||
| Postoperative myocardial infarction | 3 | 1.2 | 1 | 3.8 | 0.10 | ||||
| Postoperative stroke | 3 | 1.2 | 1 | 3.8 | 0.33 | ||||
| ICU stay (day) | 1 | 1-1 | 1 | 1-2 | 0.002 | ||||
| Hospital stay (day) | 5 | 4-6 | 6 | 5-8 | <0.001 | ||||
| IQ: Interquartile range; ICU: Intensive care unit. | |||||||||